4//SEC Filing
Hakim Nasrat A 4
Accession 0001493152-24-012832
CIK 0001053369other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:58 PM ET
Size
6.3 KB
Accession
0001493152-24-012832
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-03-29+49,534,368→ 216,649,250 total
Holdings
- 2,700,000(indirect: By IRA)
Common Stock
- 2,223,147(indirect: by Kristine Hakim)
Common Stock
Footnotes (1)
- [F1]Shares issued in settlement of compensation owed to the Reporting Person pursuant to his Employment Agreement with the issuer, dated August 1, 2013, as amended.
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeother
Related Parties
1- filerCIK 0001583742
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:58 PM ET
- Size
- 6.3 KB